Fibromyalgia
Conditions
Interventions
This is a two-arm, double-blind, randomized controlled clinical trial based on a pre-calculated sample size. Participants will be divided into two groups. The experimental group will consist of 20 wom
Sponsors
Universidade Estadual da Paraíba
Universidade Estadual da Paraíba
Eligibility
Sex/Gender
Female
Age
18 Years to 70 Years
Inclusion criteria
Inclusion criteria: Women; aged between 18 and 70 years; with a diagnosis of fibromyalgia (the diagnosis will be made by a physician referred by the patient and confirmed by a physical therapist with experience in rheumatology), taking into account the diagnostic criteria for fibromyalgia from the American College of Rheumatology.
Exclusion criteria
Exclusion criteria: Participants who are pregnant, have a history of epilepsy, have a metal implant, have undergone neurosurgery, have a psychiatric illness such as schizophrenia and bipolar disorder, otitis, and those with cognitive impairment expressed with difficulty in speaking and/or understanding and visual deficit that prevent the completion of the scales.
Design outcomes
Secondary
| Measure | Time frame |
|---|---|
| An improvement in quality of life is expected to be found by the World Health Organization Quality of Life (WHOQOL for short). | — |
Primary
| Measure | Time frame |
|---|---|
| It is expected to find a reduction in the McGill pain questionnaire scores, less impact of Fibromyalgia on quality of life assessed by the Revised Fibromyalgia Impact Questionnaire (FIQR). | — |
Countries
Brazil
Contacts
Public ContactJosé Costa Vital
Universidade Estadual da Paraíba
Outcome results
None listed